Product details
Sonendo Gentlewave Dental Endodontic
This system, known as the GentleWave System, by Sonendo Inc. (Laguna Hills, CA), consists of a console that is used to deliver the traditional irrigating solutions through a proprietary treatment instrument (TI). The tooth is accessed, canals are located, patency established and canals shaped to #20 .07 taper, the TI is sealed to the access of the tooth. The console then systematically delivers the irrigating solutions through the tip of the TI. Through the TI, irrigating solutions are delivered in a “degassed” state (no air bubbles) using acoustic and hydrodynamic cavitation. The solutions are simultaneously removed using built-in vented suction through the same TI.
While Sonendo Inc. has been around for close to 10 years, this company has made a significant investment into the marketing of this product. The clinical claims made by the company include:
- the technique provides improved removal of organic matter (pulp tissue and biofilm) a “higher standard of clean”
- the technique allows for minimal instrumentation of the canals, preserving valuable tooth structure
- the technique allows for improved cleaning of canals, lateral canals, isthmus
- 97% success rate of endodontic cases – in initial clincial studies
Sonendo Gentlewave Dental Endodontic Like many new technologies and materials that are introduced in dentistry, much of the research supporting the new technology or product comes from the manufacturer or studies that are supported by the manufacturer. It is well known that studies supported by a manufacturer tend to have bias that favors the funding source known as funding bias. As clinicians, it is up to us to evaluate the research that is presented to us as we make important decisions.
Sonendo Gentlewave Dental Endodontic A recent study titled, “12-Month Healing Rates After Endodontic Therapy Using the Novel GentleWave System: A Prospective Multicenter Clinical Study” by Sigurdsson et. al. published in the Journal of Endodontics, July 2016 is a perfect example of this problem. (click here to see the study)
The study concludes, “…the GentleWave System showed a high level of success after 12-month follow-up”. The abstract states, “The cumulative success of endodontic therapy was 97.3%. The success rates of necrotic and irreversible pulpits were 92.9% and 98.4% respectively”. The failures in design of this cohort, uncontrolled study, make these numbers less impressive than they sound.
The problem with the study design is:
- Design Bias: Bias that occurs when the design of a study selects or encourages a specific outcome. This is 12 month prospective study with no controls. How easy would it have been to make this a randomized, double blinded study and compare this new technology to the conventional endodontic approach. Then we might have a better idea if this technology actually improves the outcomes of treatment. Design bias is also evident in the discussion of this study by its failure to acknowledge the one-sided study design and in the analysis of what the results mean (see below)
- Attrition Bias: Systematic error introduced into a study by loss of participants: 75 of the 89 patients in the study returned for the 12 month follow-up. This is a drop-out rate of 15.7%. A major problem with almost all of our medical/dental studies is that we make assumptions about that 15%. Since we don’t have information on them, we exclude them from the study results. So when the study says they have 97.3% success rate – they are assuming that the 15.7% that dropped out were also successes.
- Selection/Sampling Bias: Bias introduced by the selections of participants: 72 of the 89 patients included in this study were diagnosed with irreversible pulpitis. Only 14 of 89 patients in the study had a necrotic pulp. Cases of irreversible pulpitis have the highest success rates in endodontics. To heavily weight a study with irreversible pulpitis cases creates a significant bias. A study focused on treating necrotic pulpal tissue would have been much more meaningful – especially if the study aims to prove that the GentleWave procedure will better remove the microbiota from the canal system.
- Sponsorship Bias: Refers to the overwhelming tendency of a scientific study to support the interests of the study’s financial sponsor. While the financial sponsorship is noted in the footnotes of the article, the tendency toward this bias requires a stricter methodology and implementation to reduce bias and a more clear and open discussion regarding analysis of results and clinical interpretation of these results.
The problems that we find in the discussion include:
- Citation Bias: The success rate of this study (comprised mostly of irreversible pulpitis cases) is then compared to the success rates of other previous studies (comprised of teeth with periapical radiolucencies – which means necrotic cases) as an argument of improved cleaning and efficacy is an example of selection and citation bias together.
- Internal Validity Bias: Refers to the author and reviewer’s confidence that the study design, implementation and data analysis have minimized or eliminated bias. There appears to be no effort on the part of the authors to evaluate or report any bias in the study design, implementation or data analysis.
- External Validity Bias: Refers to the degree to which the study’s design allow its findings to be able to be generalized to other groups or populations. The failure in methodology of this prospective study without positive or negative controls, make the comparisons made in the discussion in regards to improved clinicial efficacy unsubstantiated.
There are no reviews yet.